Levocetirizin Ratiopharm

Levocetirizine, the active ingredient in Levocetirizin Ratiopharm, is a second‑generation H1 antihistamine presented as an oral tablet for oral use. It treats allergic rhinitis and chronic idiopathic urticaria in adults and children when prescribed.

GNH USA supplies Levocetirizin Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levocetirizin Ratiopharm is a second‑generation H1 antihistamine used to relieve symptoms of allergic conditions. - Allergic rhinitis: reduces sneezing, nasal itching and rhinorrhoea. - Seasonal allergic rhinitis: provides relief from hay‑fever symptoms. - Chronic idiopathic urticaria: diminishes wheal formation and itching.

Levocetirizin Ratiopharm may cause a range of adverse reactions.

Common Side Effects: - Drowsiness: mild to moderate sedation. - Headache: transient cranial discomfort. - Dry mouth: reduced salivation. - Fatigue: general tiredness. - Nausea: mild gastrointestinal upset. - Abdominal pain: occasional discomfort.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips or throat. - Anaphylaxis: severe, life‑threatening allergic reaction. - Severe skin reactions: such as Stevens‑Johnson syndrome. - Tachycardia: rapid heart rate. - Hepatic enzyme elevation: abnormal liver function tests. - Blood dyscrasias: rare blood cell abnormalities.

Before initiating therapy, consider the following safety measures. - Renal function assessment: adjust dose in severe impairment. - Hepatic impairment: use with caution in liver disease. - Known hypersensitivity: avoid if patient has previous allergic reaction to levocetirizine or similar antihistamines. - Sedation risk: advise patients not to operate machinery until they know how the drug affects them. - Pregnancy and lactation: prescribe only if benefits outweigh potential risks. - Store at room temperature: keep in the original pack, protect from moisture.

Levocetirizin Ratiopharm can interact with several medicines; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole): may increase levocetirizine plasma levels. - Alcohol: additive central nervous system depression. - Other antihistamines: risk of excessive sedation.

Moderate Interactions (Monitor Closely): - CYP3A4 inducers (e.g., rifampicin): may reduce efficacy. - Theophylline: possible increase in theophylline concentrations. - Sedating CNS depressants (e.g., benzodiazepines): may enhance drowsiness.